Search
for
Sort by
Research 31–60 of 42
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States
- A mutation in the type II hair keratin KRT86 gene in a Han family with monilethrix
- Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- Validation of alopecia coding in US claims data among women of childbearing age
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Addressing Autoimmune and Immune-mediated Skin Disease Burden in Women
- Comparison of Microneedling with Platelet Rich Plasma vs Minoxidil (5%)+Finasteride (0.1%) Topical Therapy in Androgenetic Alopecia: A Randomised Clinical Study
- Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint)
- Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint)
- Response to Ranpariya et al.’s “Direct-to-consumer teledermatology platforms may have inherent conflicts of interest.”
- Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
- Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia
- Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
- Digital health platforms expand access and improve care for male androgenetic alopecia
- Direct-to-consumer teledermatology’s limitations may be addressed with greater in-person care synergy
- Aromatase deficiency in a male patient - Case report and review of the literature.
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Evaluating anti-LGBTQIA+ medical bias in large language models
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- Gender based price differences in 5% minoxidil foam: The impact of generic alternatives and bulk packaging
- A systematic appraisal of emerging alternative therapies in men’s health and wellness
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)